blockbuster-therapy-predictor

# Blockbuster Therapy Predictor

Comprehensive analytics tool for forecasting breakthrough therapeutic technologies by integrating multi-dimensional data sources including clinical development pipelines, intellectual property landscapes, and capital market indicators.

## Features

- **Multi-Source Data Integration**: Aggregates clinical trials, patents, and funding data
- **Predictive Scoring**: Calculates Blockbuster Index combining maturity, market potential, and momentum
- **Technology Landscape Mapping**: Tracks 10+ emerging therapeutic platforms
- **Investment Intelligence**: Provides data-driven R&D and investment recommendations
- **Trend Analysis**: Identifies acceleration patterns and inflection points

## Usage

### Basic Usage

```bash
# Run complete analysis with all technologies
python scripts/main.py

# Analyze specific technologies
python scripts/main.py --tech PROTAC,mRNA,CRISPR

# Output in JSON format
python scripts/main.py --output json
```

### Parameters

| Parameter | Type | Default | Required | Description |
|-----------|------|---------|----------|-------------|
| `--mode` | str | full | No | Analysis mode: full or quick |
| `--tech` | str | None | No | Comma-separated list of technologies to analyze |
| `--output` | str | console | No | Output format: console or json |
| `--threshold` | float | 0 | No | Minimum blockbuster index threshold (0-100) |
| `--save` | str | None | No | Save report to file path |

### Advanced Usage

```bash
# Analyze high-potential technologies only (index ≥70)
python scripts/main.py \
  --threshold 70 \
  --output json \
  --save high_potential_report.json

# Quick analysis of specific platforms
python scripts/main.py \
  --mode quick \
  --tech CAR-T,ADC,Bispecific \
  --output console
```

## Output

### Console Output

```
🏆 BLOCKBUSTER THERAPY PREDICTOR Report
Generated: 2026-02-15 10:30:00
Technologies analyzed: 10

📊 Technology Rankings
Rank  Technology       Blockbuster Index    Maturity    Market Potential    Momentum    Recommendation
🥇 1   mRNA             85.2                 78.5        92.1                88.0        Strongly Recommended
🥈 2   CAR-T            82.3                 85.2        78.5                75.0        Strongly Recommended
🥉 3   CRISPR           79.8                 72.3        88.2                68.0        Recommended
```

### JSON Output Structure

```json
{
  "generated_at": "2026-02-15T10:30:00",
  "total_routes": 10,
  "rankings": [
    {
      "rank": 1,
      "tech_name": "mRNA",
      "blockbuster_index": 85.2,
      "maturity_score": 78.5,
      "market_potential_score": 92.1,
      "momentum_score": 88.0,
      "recommendation": "Strongly Recommended",
      "key_drivers": ["Multiple Phase III trials", "Rapid patent growth"],
      "risk_factors": ["Regulatory uncertainties"],
      "timeline_prediction": "First product expected in 2-4 years"
    }
  ]
}
```

## Scoring Methodology

### Blockbuster Index Formula

```
Blockbuster Index = (Market Potential × 0.5) + (Maturity × 0.3) + (Momentum × 0.2)
```

### Component Scores

| Component | Weight | Factors |
|-----------|--------|---------|
| **Market Potential** | 50% | Market size, unmet need, competition |
| **Maturity** | 30% | Clinical stage, patent depth, funding stage |
| **Momentum** | 20% | Patent growth, funding activity, clinical progress |

### Investment Recommendation Thresholds

| Blockbuster Index | Recommendation | Action |
|-------------------|----------------|--------|
| ≥ 80 | **Strongly Recommended** | Prioritize R&D investment |
| 60-79 | **Recommended** | Active monitoring and early partnerships |
| 40-59 | **Watch** | Monitor milestones; reassess in 6-12 months |
| < 40 | **Cautious** | Minimal investment; consider divestment |

## Supported Technologies

| Technology | Category | Description |
|------------|----------|-------------|
| PROTAC | Protein Degradation | Proteolysis Targeting Chimera |
| mRNA | Nucleic Acid Drugs | Messenger RNA therapy platform |
| CRISPR | Gene Editing | CRISPR-Cas gene editing technology |
| CAR-T | Cell Therapy | Chimeric Antigen Receptor T-cell therapy |
| Bispecific | Antibody Drugs | Bispecific antibody technology |
| ADC | Antibody Drugs | Antibody-Drug Conjugate |
| RNAi | Nucleic Acid Drugs | RNA interference therapy |
| Gene Therapy | Gene Therapy | AAV vector gene therapy |
| Allogeneic | Cell Therapy | Universal/Allogeneic cell therapy |
| Cell Therapy | Cell Therapy | General cell therapy platform |

## Technical Difficulty: **MEDIUM**

⚠️ **AI自主验收状态**: 需人工检查

This skill requires:
- Python 3.8+ environment
- Basic understanding of biotech investment analysis
- Access to clinical trial, patent, and funding databases (optional)

## Dependencies

### Required Python Packages

```bash
pip install -r requirements.txt
```

### Requirements File

```
dataclasses
enum
```

## Risk Assessment

| Risk Indicator | Assessment | Level |
|----------------|------------|-------|
| Code Execution | Python scripts executed locally | Medium |
| Network Access | No external API calls in mock mode | Low |
| File System Access | Read/write report files only | Low |
| Instruction Tampering | Standard prompt guidelines | Low |
| Data Exposure | Output files saved to workspace | Low |

## Security Checklist

- [x] No hardcoded credentials or API keys
- [x] No unauthorized file system access (../)
- [x] Output does not expose sensitive information
- [x] Prompt injection protections in place
- [x] Input file paths validated (no ../ traversal)
- [x] Output directory restricted to workspace
- [x] Script execution in sandboxed environment
- [x] Error messages sanitized (no stack traces exposed)
- [x] Dependencies audited

## Prerequisites

```bash
# Python dependencies
pip install -r requirements.txt
```

## Evaluation Criteria

### Success Metrics
- [ ] Successfully executes main functionality
- [ ] Output meets quality standards
- [ ] Handles edge cases gracefully
- [ ] Performance is acceptable

### Test Cases
1. **Basic Functionality**: Run without arguments → Expected output with all technologies
2. **Technology Filter**: Use --tech flag → Only specified technologies analyzed
3. **JSON Output**: Use --output json → Valid JSON format output
4. **Threshold Filter**: Use --threshold 70 → Only technologies with index ≥70 shown

## Lifecycle Status

- **Current Stage**: Draft
- **Next Review Date**: 2026-03-15
- **Known Issues**: None
- **Planned Improvements**: 
  - Integration with real-time data APIs
  - Additional technology platforms
  - Enhanced visualization capabilities

## References

See `references/` for:
- Historical blockbuster case studies
- Clinical trial data sources
- Patent analysis methodologies
- Investment scoring frameworks

## Limitations

- **Data Source**: Uses mock data for demonstration; real-time data integration required for production use
- **Prediction Accuracy**: Model provides indicative scores; not investment advice
- **Technology Coverage**: Limited to pre-configured technology platforms
- **Market Dynamics**: Cannot predict black swan events or regulatory changes
- **Regional Bias**: Data primarily focused on US/EU markets

---

**⚠️ DISCLAIMER: This tool provides quantitative analysis for decision support only. All investment and R&D decisions should incorporate qualitative domain expertise, regulatory consultation, and comprehensive due diligence. Past performance of historical blockbusters does not guarantee future success of emerging technologies.**